FDA Drug Application (022203) for ASTEPRO by MEDA PHARMS

Back to FDA Applications sponsored by MEDA PHARMS

Application Number022203
Product Number001
FormSPRAY, METERED;NASAL
DosageEQ 0.125MG BASE/SPRAY
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameASTEPRO
Active IngredientAZELASTINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient AZELASTINE HYDROCHLORIDE5


Back to FDA Applications sponsored by MEDA PHARMS